Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux
Fan Lin(Utrecht University), Olaf van Tellingen(The Netherlands Cancer Institute), Dieta Brandsma(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Mark C. de Gooijer(Manchester Academic Health Science Centre), Diana Hanekamp(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Jos H. Beijnen(The Netherlands Cancer Institute)
Cited by 22
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
|PubMed|2002|507
Clinical Pharmacokinetics of Cyclophosphamide
|Clinical Pharmacokinetics|2005|451